Atlas Trials

The Effect of Early Versus Standard Central Line Removal on Growth of Very Low Birth Weight Premature Infants

Clinical trial NCT03730883 · UNKNOWN

Trial details

NCT number
NCT03730883
Sponsor
Princess Anna Mazowiecka Hospital, Warsaw, Poland
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Growth FailureCLABSI - Central Line Associated Bloodstream Infection
Start date
2019-01-26
Primary completion
2022-04-10
Enrollment
214

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.